Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AEHR TEST SYSTEMS
Report date January 26, 2022 · Filed January 27, 2022
Section 16 reporting ended · disclosed 2022-01-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-01-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-01-26 · Sale · Disposed 6,025 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.86, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2: 10,348 shares subject to unvested restricted stock units were cancelled upon employment termination. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.86, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F2: 10,348 shares subject to unvested restricted stock units were cancelled upon employment termination.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2022 Filed Jan 27, 2022 22:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,025 | $12.37 | $74,543.71 |
DisclosureSEC source: 0001654954-22-000832 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · FORMER VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.86, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: 10,348 shares subject to unvested restricted stock units were cancelled upon employment termination. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001654954-22-000737 · section16.xml · derivative · entry 3 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,625 Underlying: Common Stock · 3,125 shares Expires 2027-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 15,350 | $12.35 | $189,615.48 |
DisclosureSEC source: 0001654954-22-000737 · section16.xml · nonDerivative · entry 2 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,373 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.66, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 3,125 | $1.22 | $3,812.50 |
DisclosureSEC source: 0001654954-22-000737 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2022 Filed Jan 15, 2022 02:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 248 | $13.67 | $3,390.16 |
DisclosureSEC source: 0001654954-22-000545 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,598 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 20:17 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001654954-21-013091 · section16.xml · derivative · entry 2 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 3,125 shares Expires 2027-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 20:17 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 3,125 | $1.22 | $3,812.50 |
DisclosureSEC source: 0001654954-21-013091 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 230 | $20.46 | $4,705.80 |
DisclosureSEC source: 0001654954-21-011159 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,721 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 14,125 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001654954-21-011064 · section16.xml · derivative · entry 5 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 14,125 shares Expires 2027-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 14,125 | $1.22 | $17,232.50 |
DisclosureSEC source: 0001654954-21-011064 · section16.xml · nonDerivative · entry 3 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001654954-21-011064 · section16.xml · derivative · entry 4 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,000 Underlying: Common Stock · 14,000 shares Expires 2027-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 17,000 | $18.80 | $319,600.00 |
DisclosureSEC source: 0001654954-21-011064 · section16.xml · nonDerivative · entry 2 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,826 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $19.67, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 14,000 | $1.22 | $17,080.00 |
DisclosureSEC source: 0001654954-21-011064 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 01:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $1.19 | $3,570.00 |
DisclosureSEC source: 0001654954-21-010780 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,826 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 9,073 | $14.24 | $129,199.52 |
DisclosureSEC source: 0001654954-21-010602 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,826 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.76 to $14.73, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 30, 2021 Filed Aug 2, 2021 20:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,500 | $5.66 | $14,150.00 |
DisclosureSEC source: 0001654954-21-008421 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,899 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 19:07 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 11,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007915 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,399 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 8,167 | $2.50 | $20,417.50 |
DisclosureSEC source: 0001654954-21-007707 · section16.xml · nonDerivative · entry 3 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,573 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the transactions described in footnote 1 and footnote 2. This does not represent a sale by the Reporting Person. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007707 · section16.xml · nonDerivative · entry 2 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,740 F2 · shares: Represents shares of common stock issued for bonus. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007707 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,460 F1 · shares: RSU shares issued in lieu of cash for the restoration of 30% salary deduction for the six months ended May 31, 2021. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 19:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 346 | $2.18 | $754.28 |
DisclosureSEC source: 0001654954-21-004402 · section16.xml · nonDerivative · entry 2 Brannan Michael A. · CIK 0001807248 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the bonus described in footnote 1. This does not represent a sale by the Reporting Person. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 19:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 1,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-004402 · section16.xml · nonDerivative · entry 1 Brannan Michael A. · CIK 0001807248 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,606 F1 · shares: Represents shares of common stock issued for bonus. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.